An expert Q&A on the US Patent and Trademark Office’s (USPTO’s) 2025 guidance memoranda addressing the Patent Trial and Appeal Board’s (PTAB’s) approach to discretionary denials of inter partes review ...
Moderna will pay up to $2.25B to settle a patent lawsuit over lipid nanoparticle technology used in its COVID-19 vaccine.
The Rise of ‘Settled Expectations’ In USPTO Review and the Fallout for Patent Owners and Challengers
The landscape for discretionary denials at PTAB is evolving quickly; both patent challengers and owners must adapt their strategies to ensure they are not left behind by the USPTO’s new approach. The ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
“The Federal Circuit… ruled that such a due process violation could only be asserted by whoever claimed to be the true [patent owner].” Today, the U.S. Court of Appeals for the Federal Circuit (CAFC) ...
Each year, companies invest significant financial resources building and maintaining patent portfolios. But instead of ...
"seven patents covering hybrid bonding technology and three patents covering advanced process node technology." How does a lawsuit like this even work when AMD does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results